<DOC>
	<DOCNO>NCT02190864</DOCNO>
	<brief_summary>Our long-term goal integrate non-small cell lung cancer patient treatment preference clinical treatment planning .</brief_summary>
	<brief_title>Patient-Defined Treatment Success Preferences Stage IV Lung Cancer Patients</brief_title>
	<detailed_description>The follow specific aim propose : Aim 1 : Determine whether individual patient ' preference , characteristic , treatment experience affect definition treatment success . Aim 2 : Determine best predict real-life patient ' treatment choice base patient ' preference adverse event . Aim 3 : Determine whether physician likely change oncologic clinical practice receive detailed communication patient ' preference adverse event .</detailed_description>
	<criteria>Willing able provide consent Greater equal 19 year age Diagnosed stage IV nonsmall cell lung cancer ( NSCLC ) Able understand speak English Eligible undergo chemotherapy stage IV NSCLC , include , limited , : 1. yet start chemo 2. currently undergo chemo stage IV NSCLC 3. complete first line stage IV NSCLC chemo progress maintenance stage IV NSCLC within last 30 day 4. elect chemo elsewhere one study sit 5. decline chemo Age &lt; 19 year Not willing and/or able provide consent Not able understand speak English Not eligible undergo chemotherapy stage IV NSCLC</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>